• Washington DC |
  • New York |
  • Toronto |
  • Distribution: (800) 510 9863
Friday, November 20, 2026
  • Login
No Result
View All Result
NEWSLETTER
New Edge Times
  • World
  • U.S.
  • Politics
  • Business
  • Science
  • Tech
  • Youth
  • Entertainment
    • All
    • Arts
    • Gaming
    • Movie
    • Music
    Review: Asmik Grigorian Stars in a New Met Opera ‘Jenufa’

    Review: Asmik Grigorian Stars in a New Met Opera ‘Jenufa’

    ‘The Hunger Games: Sunrise on the Reaping’ Review: Another Tribute

    ‘The Hunger Games: Sunrise on the Reaping’ Review: Another Tribute

    Video: Will A.I. Make This Tedious Hollywood Job Easier?

    Video: Will A.I. Make This Tedious Hollywood Job Easier?

    Anne Teresa De Keersmaeker Comes Full Circle, Spinning to Philip Glass

    Anne Teresa De Keersmaeker Comes Full Circle, Spinning to Philip Glass

    After ‘Boston,’ Where Does Stella Lefty Go?

    After ‘Boston,’ Where Does Stella Lefty Go?

    ‘The Fantasticks’ Review: A Gender Swap for a Still-Tender Story

    ‘The Fantasticks’ Review: A Gender Swap for a Still-Tender Story

    5 Takeaways From the 2027 Grammy Nominations.

    5 Takeaways From the 2027 Grammy Nominations.

    Why Robert Pattinson Could Be a Great James Bond

    Why Robert Pattinson Could Be a Great James Bond

    • Gaming
    • Movie
    • Music
    • Arts
  • Sports
  • Lifestyle
    • All
    • Fashion
    • Food
    • Health
    • Travel
    Street Style Look of the Week: ‘Old Man’ Style and ‘Subliminal Messaging’

    Street Style Look of the Week: ‘Old Man’ Style and ‘Subliminal Messaging’

    And Now, Melissa Clark’s Mashed Potatoes

    And Now, Melissa Clark’s Mashed Potatoes

    Restaurant Review: At Faux, the Scene-y NYC Bistro Enters Its Next Generation

    Restaurant Review: At Faux, the Scene-y NYC Bistro Enters Its Next Generation

    Jessica Craig-Martin Is Thrilled to Decline an Invitation

    Jessica Craig-Martin Is Thrilled to Decline an Invitation

    How the Measles Virus Makes Your Immune System Forget

    How the Measles Virus Makes Your Immune System Forget

    Fearing Chinese Rivals, U.S. Biotech Adopts a New Norm: Share Nothing

    Fearing Chinese Rivals, U.S. Biotech Adopts a New Norm: Share Nothing

    A Hot Springs Road Trip in Southern California

    A Hot Springs Road Trip in Southern California

    Pilots Kept Contact With Controllers During Nationwide Halt to Flights

    Pilots Kept Contact With Controllers During Nationwide Halt to Flights

    • Fashion
    • Food
    • Health
    • Travel
  • Reviews
  • Trending
  • World
  • U.S.
  • Politics
  • Business
  • Science
  • Tech
  • Youth
  • Entertainment
    • All
    • Arts
    • Gaming
    • Movie
    • Music
    Review: Asmik Grigorian Stars in a New Met Opera ‘Jenufa’

    Review: Asmik Grigorian Stars in a New Met Opera ‘Jenufa’

    ‘The Hunger Games: Sunrise on the Reaping’ Review: Another Tribute

    ‘The Hunger Games: Sunrise on the Reaping’ Review: Another Tribute

    Video: Will A.I. Make This Tedious Hollywood Job Easier?

    Video: Will A.I. Make This Tedious Hollywood Job Easier?

    Anne Teresa De Keersmaeker Comes Full Circle, Spinning to Philip Glass

    Anne Teresa De Keersmaeker Comes Full Circle, Spinning to Philip Glass

    After ‘Boston,’ Where Does Stella Lefty Go?

    After ‘Boston,’ Where Does Stella Lefty Go?

    ‘The Fantasticks’ Review: A Gender Swap for a Still-Tender Story

    ‘The Fantasticks’ Review: A Gender Swap for a Still-Tender Story

    5 Takeaways From the 2027 Grammy Nominations.

    5 Takeaways From the 2027 Grammy Nominations.

    Why Robert Pattinson Could Be a Great James Bond

    Why Robert Pattinson Could Be a Great James Bond

    • Gaming
    • Movie
    • Music
    • Arts
  • Sports
  • Lifestyle
    • All
    • Fashion
    • Food
    • Health
    • Travel
    Street Style Look of the Week: ‘Old Man’ Style and ‘Subliminal Messaging’

    Street Style Look of the Week: ‘Old Man’ Style and ‘Subliminal Messaging’

    And Now, Melissa Clark’s Mashed Potatoes

    And Now, Melissa Clark’s Mashed Potatoes

    Restaurant Review: At Faux, the Scene-y NYC Bistro Enters Its Next Generation

    Restaurant Review: At Faux, the Scene-y NYC Bistro Enters Its Next Generation

    Jessica Craig-Martin Is Thrilled to Decline an Invitation

    Jessica Craig-Martin Is Thrilled to Decline an Invitation

    How the Measles Virus Makes Your Immune System Forget

    How the Measles Virus Makes Your Immune System Forget

    Fearing Chinese Rivals, U.S. Biotech Adopts a New Norm: Share Nothing

    Fearing Chinese Rivals, U.S. Biotech Adopts a New Norm: Share Nothing

    A Hot Springs Road Trip in Southern California

    A Hot Springs Road Trip in Southern California

    Pilots Kept Contact With Controllers During Nationwide Halt to Flights

    Pilots Kept Contact With Controllers During Nationwide Halt to Flights

    • Fashion
    • Food
    • Health
    • Travel
  • Reviews
  • Trending
No Result
View All Result
New Edge Times
No Result
View All Result
Home Lifestyle Health

Users of New Weight Loss Drug Had Lower Blood Pressure in Study

by New Edge Times Report
February 5, 2024
in Health
Users of New Weight Loss Drug Had Lower Blood Pressure in Study
Share on FacebookShare on Twitter

A study of the weight loss drug tirzepatide showed that people who took it had significantly lower blood pressures after 36 weeks of using the medication.

Tirzepatide, made by Eli Lilly, is used to treat Type 2 diabetes, under the brand name Mounjaro, and to treat obesity, under the brand name Zepbound. It is the latest among a new class of weight loss drugs, and its chief competitor is semaglutide, made by Novo Nordisk and sold as Ozempic for diabetes and as Wegovy for weight loss. For both drugs, researchers have been assessing whether they have additional effects that go beyond weight loss.

The blood pressure study, supported by Eli Lilly and published on Monday in the journal Hypertension, was part of a larger effort to assess tirzepatide’s effects on weight loss. Researchers had already found that people who took the drug had lower blood pressures when readings were taken in a doctor’s office. The new study applied a more rigorous criteria: Did participants taking the drug have lower pressures when measured with a 24-hour monitor?

They did. Those taking the drug had systolic blood pressures — the pressure on blood vessels when the heart contracts — that were from 7.4 to 10.0 milligrams of mercury lower than those of participants taking a placebo. Systolic pressure is believed to be an accurate predictor of heart disease risk.

The blood pressure reduction, said Dr. James de Lemos, a cardiologist at the University of Texas Southwestern Medical Center and the lead author of the study, is about what would be expected with a full dose of a blood pressure medicine. As such, he said, the drug can be useful for people trying to control their pressure and reduce their heart attack and stroke risk (although the study does not suggest tirzepatide be substituted for other blood pressure medications).

But, he noted, it was not possible to distinguish the effect — if any — that the drug had on blood pressure from the well-known effect that weight loss has on reducing blood pressure.

Dr. Benjamin Ansell, a blood pressure specialist at the University of California, Los Angeles, who was not involved in the study, said that he did not find the result surprising.

”One could also hypothesize that weight loss permitted more exercise or improved sleep/reduced sleep apnea, any of which could ‘additionally’ lower blood pressure,” he wrote in an email.

A more interesting effect of a drug in this class, Dr. Ansell noted, is the recent discovery that semaglutide helps patients with a condition known as heart failure with preserved ejection fraction — a common outcome of obesity and high blood pressure. It is a chronic and progressive disease that is debilitating and destroys quality of life. Most patients with this sort of heart failure have obesity, and obesity is thought to contribute to the disease and its progression.

In a large study by Novo Nordisk, patients taking semaglutide had fewer symptoms of the disease and were better able to exercise, researchers found.

That result, Dr. Ansell added, “showed a profound clinical significance in improving their function while reducing hospitalizations.”

And that finding adds to another Novo Nordisk result showing that semaglutide reduced the risk of cardiac events like heart attacks.

Previous Post

Best and Worst Moments From the 2024 Grammys

Next Post

Here’s What’s in the Senate’s $118 Billion Ukraine and Border Deal

Related Posts

How the Measles Virus Makes Your Immune System Forget
Health

How the Measles Virus Makes Your Immune System Forget

by New Edge Times Report
November 17, 2026
Fearing Chinese Rivals, U.S. Biotech Adopts a New Norm: Share Nothing
Health

Fearing Chinese Rivals, U.S. Biotech Adopts a New Norm: Share Nothing

by New Edge Times Report
November 17, 2026
An Intriguing Approach to Slow Alzheimer’s Shows Mixed Results
Health

An Intriguing Approach to Slow Alzheimer’s Shows Mixed Results

by New Edge Times Report
November 16, 2026
Leave Comment
New Edge Times

© 2025 New Edge Times or its affiliated companies. All rights reserved.

Navigate Site

  • About
  • Advertise
  • Terms & Conditions
  • Privacy Policy
  • Disclaimer
  • Contact

Follow Us

No Result
View All Result
  • World
  • U.S.
  • Politics
  • Business
  • Science
  • Tech
  • Youth
  • Entertainment
    • Gaming
    • Movie
    • Music
    • Arts
  • Sports
  • Lifestyle
    • Fashion
    • Food
    • Health
    • Travel
  • Reviews
  • Trending

© 2025 New Edge Times or its affiliated companies. All rights reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In